The May-Hegglin anomaly: a rare cause of a common complaint
- 1 March 2021
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 14 (3), e235432
- https://doi.org/10.1136/bcr-2020-235432
Abstract
May-Hegglin anomaly is the presentation of a qualitative platelet disorder characterised by large platelets, thrombocytopenia and granulocyte inclusions as a result of mutations in the MYH9 gene. Though often overlooked given its rarity, it should be considered in patients who present with epistaxis, bruising, menorrhagia and easy bleeding as it can be mistaken for other diagnoses resulting in unnecessary treatments and tests. Our case study reports one presentation of this anomaly and can help broaden awareness of the presentation of this type of patient.Keywords
This publication has 7 references indexed in Scilit:
- Clinic, pathogenic mechanisms and drug testing of two inherited thrombocytopenias, ANKRD26-related Thrombocytopenia and MYH9-related diseasesEuropean Journal of Medical Genetics, 2018
- MYH9: Structure, functions and role of non-muscle myosin IIA in human diseaseGene, 2018
- Macrothrombocytopenia With Döhle Body-Like Granulocyte Inclusions: A Case Report of May-Hegglin Anomaly in a 33-Year-Old White Woman With an Update on the Molecular Findings ofMYH9-Related DiseaseLaboratory Medicine, 2016
- A novel MYH9 mutation in a patient with MYH9 disorders and platelet size-specific effect of romiplostim on macrothrombocytopeniaAnnals of Hematology, 2015
- May Hegglin Anomaly: Rare Entity with Review of LiteratureIndian Journal of Hematology and Blood Transfusion, 2011
- Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutationsBlood, 2010
- Thrombocytopenia, Giant Platelets, and Leukocyte Inclusion Bodies (May-Hegglin Anomaly): Clinical and Laboratory FindingsAmerican Journal Of Medicine, 1998